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Abstract
Background: In Ethiopia a tiebreaker algorithm using 3 rapid diagnostic tests (RDTs) in series is used to diagnose
HIV. Discordant results between the first 2 RDTs are resolved by a third ‘tiebreaker’ RDT. Médecins Sans Frontières
uses an alternate serial algorithm of 2 RDTs followed by a confirmation test for all double positive RDT results. The
primary objective was to compare the performance of the tiebreaker algorithm with a serial algorithm, and to evaluate
the addition of a confirmation test to both algorithms. A secondary objective looked at the positive predictive value
(PPV) of weakly reactive test lines.
Methods: The study was conducted in two HIV testing sites in Ethiopia. Study participants were recruited sequentially
until 200 positive samples were reached. Each sample was re-tested in the laboratory on the 3 RDTs and on a simple to
use confirmation test, the Orgenics Immunocomb Combfirm® (OIC). The gold standard test was the Western Blot, with
indeterminate results resolved by PCR testing.
Results: 2620 subjects were included with a HIV prevalence of 7.7%. Each of the 3 RDTs had an individual specificity of
at least 99%. The serial algorithm with 2 RDTs had a single false positive result (1 out of 204) to give a PPV of 99.5%
(95% CI 97.3%-100%). The tiebreaker algorithm resulted in 16 false positive results (PPV 92.7%, 95% CI: 88.4%-95.8%).
Adding the OIC confirmation test to either algorithm eliminated the false positives. All the false positives had at least
one weakly reactive test line in the algorithm. The PPV of weakly reacting RDTs was significantly lower than those with
strongly positive test lines.
Conclusion: The risk of false positive HIV diagnosis in a tiebreaker algorithm is significant. We recommend abandoning
the tie-breaker algorithm in favour of WHO recommended serial or parallel algorithms, interpreting weakly reactive test
lines as indeterminate results requiring further testing except in the setting of blood transfusion, and most importantly,
adding a confirmation test to the RDT algorithm. It is now time to focus research efforts on how best to translate this
knowledge into practice at the field level.
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Background
Ethiopia has a HIV prevalence of 1.3% (95% CI 1.2%-1.5%)
in the adult population [1]. Considerable progress has
been made over the last decade in scaling up access to
testing across the country. In 2011, the number of people
accessing HIV testing reached close to 10 million [2].
Scale up of HIV testing is possible due to diagnostic
algorithms that employ HIV rapid diagnostic tests (RDTs).
In Ethiopia, a tiebreaker regimen consisting of 3 RDTs in
series is the national algorithm chosen after a thorough
evaluation period. It uses HIV (1 + 2) Antibody Colloidal
Gold (KHB, Shanghai Kehua Bio-engineering Co Ltd,
China) as a screening test, followed by HIV 1/2
STAT-PAK® (Chembio Diagnostics, USA) if positive.
Where the result of STAT-PAK® is discordant with
KHB, a third test, Unigold™ HIV (Trinity Biotech, Ireland),
is used as a tiebreaker to determine the result.
Rapid diagnostic tests are essential tools to screen for
HIV, and are designed for use with confirmatory tests
such as Western Blot to diagnose infection. However
given resource constraints, WHO has developed testing
guidelines that use 2–3 RDTs together in an algorithm
to diagnose HIV [3]. While these algorithms allow
decentralisation of HIV testing and scale up of access,
they can come with the compromise of false positive
results. This risk is described in a number of different
studies [4-8] and has been shown to vary geographically
and over time [9]. The risk of false positive results is
linked to cross-reactivity, whereby non-HIV antibodies
or protein in the blood falsely react with the antigens of
the HIV RDTs. Where both RDTs cross react, a false
positive diagnosis will result.
A number of studies have shown a link between false
positive results and a weaker than usual test line on the
RDT [4,5,8,10-13]. However current manufacturers’
recommendations are that any colour of the test line is
interpreted as positive, which can result in misdiagnosis of
HIV if a second test is also positive.
Médecins Sans Frontières-Operational Centre Amsterdam
(MSF) opened a project in Humera to support the Tigray
Regional Health Bureau with diagnosing and treating
visceral leishmaniasis (VL) in 1997. HIV testing activities
started the following year, with anti-retroviral treatment
(ART) available from 2004. In 2008, MSF handed over the
project to the Health Bureau. MSF has worked in Abdurafi
providing diagnosis and treatment for VL and HIV since
2004. In both sites, health care staff and patients identified
concerns about possible misclassification of HIV infection.
In response, MSF introduced an alternate algorithm
in Abdurafi, using two RDTs in series, followed by a
confirmation test. The confirmation test used, the
Orgenics Immunocomb® II, HIV 1&2 Combfirm (OIC),
separately detects the p24, p31, gp41, gp120, and gp36
antibodies. It is performed by peripheral laboratory staff
and produces results in two hours at a cost of $5 per test.
The OIC in the first 15 months of use in Abdurafi
identified 7.1% of positive results on a serial algorithm of
Determine HIV-1/2 (Abbott Laboratories) and Unigold™
to be false positive reactions [14]. However the OIC is not
part of the national algorithm, and there is little published
on its performance characteristics.
We designed a study using standard WHO methodology
to evaluate the performance of different RDT algorithms
including the addition of the OIC confirmation test. We
included a secondary objective on the predictive value of
weak positive test lines. Two other objectives looking at
the potential association between VL infection and false
positive results and a novel method of confirmation testing,
are reported separately.
Methods
Setting
The study site was in a MSF supported health centre in
Abdurafi and a zonal hospital in Humera. The populations
included residents as well as high numbers of migrant
workers who are present seasonally. Testing took place in
the designated counselling and testing (CT) centres in
each site, in addition to the antenatal clinic, hospital and
outpatient department in Humera.
Inclusion criteria
All clients, aged > = 5 years, presenting to be tested for
HIV in the study sites were invited to participate in the
study. Study participants underwent informed consent
procedures and had a written consent form signed by
the participant or the guardian.
Sample size
A sample size of 200 serial algorithm positive and 200
algorithm negative participants was chosen based on the
WHO guidance for evaluation of RDTs [15]. To achieve
the sample, all KHB positive samples were included along
with every 10th KHB negative sample until a minimum of
200 positive samples were reached.
Information collected
Information recorded included age, sex, village, residency
status (migrant worker, settler, resident, commercial sex
worker, other), reason for testing, and time of most recent
risk exposure. Clinical information recorded included
CD4 count and presence/absence of active VL infection.
Testing
Initial testing was done on whole blood using the KHB-
STAT/PAK®/Unigold™ tiebreaker algorithm in Humera,
and on plasma using the KHB/STAT-PAK® serial algorithm
in Abdurafi. In the laboratory, samples were tested with 3
RDTs (KHB, STAT-PAK®, and Unigold™) on whole blood
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and plasma. Laboratory technicians were blinded to the
CT results. All tests were performed according to
manufacturer’s instructions. Invalid tests where the con-
trol line did not appear were discarded and repeated on
new test devices according to manufacturers’ instructions.
Tests were interpreted as positive when there was any
colouration of the test line. Positive results were further
classified as weak positive when the test line was signifi-
cantly thinner and weaker than normal. A photo card was
developed to guide interpretation.
All samples underwent testing by OIC and Western
Blot with technicians blinded to earlier results. OIC was
performed at each study site while the Western Blots
were all performed at the MSF laboratory in Abdurafi.
Interpretation of OIC was based on the stricter criteria
employed in the Agence Nationale d’Accréditation et
d’Evaluation en Santé guidelines [16]. Three to four
spots were considered positive, two as indeterminate,
and zero or one spot as negative. Gp36 was not included
in determining the number of reactions.
Western Blot (WB) testing was performed using MP
Diagnostics HIV Blot 2.2 at the MSF Abdurafi laboratory.
Interpretation of results was based on American Red
Cross recommendations [17].
Samples indeterminate on WB or OIC were repeated and
if still indeterminate, underwent DNA PCR examination
using Roche Amplicor DNA v1.5 on dry blood spots (DBS)
at the Ethiopian Health and Nutrition Research Institute
(EHNRI) laboratory based in Addis Ababa, allowing
diagnosis of subtypes A-D. The Global Clinical and Viral
Laboratory in South Africa provided quality control for
PCR and confirmed results using Cobas® AmpliPrep/Cobas®
TaqMan® HIV-1 Qual test which detects HIV subtypes A to
H. Where results between the two labs were discrepant, the
result from South Africa was used.
The final gold standard result was that of the Western
Blot, and where Western Blot was indeterminate, the
PCR result.
Quality control
All staff underwent training on the study standard
operating procedures by the MSF laboratory supervisor,
and received regular monitoring and supervision. As
previously described all RDT results were controlled at
the laboratory, and discrepant results repeated.
Analysis
The RDT result on plasma was considered the final
result for the purposes of the analysis. As the samples
received all 3 RDTs in the laboratory, each sample
regardless of the initial algorithm was evaluated for
both the serial and tiebreaker algorithm. It was also
possible to calculate an alternate algorithm to give
results for a serial KHB/Unigold™ algorithm, and a
KHB/Unigold™ /STAT-PAK® tiebreaker algorithm. Dis-
cordant test results (one RDT positive, the other
negative) were classified as negative, and indeterminate
OIC results as positive for the calculation of predictive
values and sensitivity/specificity.
Predictive values and sensitivity and specificity were
estimated from the 2 × 2 table of observed results after
weighting based on the sampling proportion of the
KHB positive and negative samples. Confidence inter-
vals for each of the test parameters were calculated
using exact binomial intervals. PPVs of RDT algorithms
from the main sample were compared using an ana-
logue of McNemar’s statistic (Z score) derived from a
marginal logistic regression model [18]. Where the lo-
gistic regression model was unable to give a score a
bias-corrected bootstrap was employed. Fisher’s exact
test was used to compare categorical variables for the
false positive analysis with the Mann–Whitney test for
continuous variables.
Statistical analysis was done using Stata version 12
(StataCorp, Texas, USA).
Ethical review
The study received approval from the MSF Ethics Review
Board, the EHNRI Research and Ethical Clearance
Committee, and the National Research Ethics Review
Committee, Ministry of Science and Technology in Ethiopia.
Results
2622 individuals were screened from December 2010 to
July 2011, 1297 (59.2%) in Humera and 895 (40.8%) in
Abdurafi. 430 individuals were eligible for analysis,
representing all KHB positives and 10% of KHB nega-
tives. One sample was excluded due to missing WB
and PCR results, and another was excluded due to a
duplicate identity number. This resulted in a total
sample of 428. HIV prevalence was 7.7% (203/2620). A
description of the demographics of the study participants
is found in Table 1.
The WB identified 201 positives, 166 negatives and 61
indeterminates (59 of which were negative on PCR and
2 positive). The OIC identified 198 positives, 223
negatives and 7 indeterminates (5 positive on PCR and 2
negative). There were no positive HIV-2 results on either
the OIC or WB.
Test performance measures of the individual RDTs are
in Table 2. Each RDT had a specificity of 99% or greater.
Serial Algorithms
The KHB/STAT-PAK® serial algorithm had one false
positive result and no false negatives. There were 22
discordant results, all of which were resolved negative
by WB and PCR.
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The addition of the OIC confirmatory test to the
KHB/STATPAK® algorithm eliminated the false positive
result. There was no statistically significant differ-
ence in PPV between the serial KHB/STAT-PAK® al-
gorithm and the corresponding serial OIC algorithm
(p = 0.33).
An alternate serial algorithm with KHB/Unigold™
resulted in 16 false positives, 0 false negatives, and 9
discordants, 7 (77.8%) of which were resolved to be
negative. The addition of the OIC test to the algorithm
significantly improved the PPV (p = 0.004). Details are
in Tables 3 and 4.
Tiebreaker algorithm
The KHB/STAT-PAK®/Unigold™ tiebreaker algorithm
yielded 16 false positive results and 0 false negatives as
shown in Table 3. Addition of the OIC test to the algo-
rithm eliminated the false positive results and added 6
indeterminate results, 5 of which were resolved positive.
The PPV of the OIC algorithm was significantly improved
compared to the tiebreaker alone (p < 0.001).
An alternate tiebreaker algorithm of KHB/Unigold™/
STAT-PAK® also resulted in 16 false positives and no false
negatives. Addition of the OIC test eliminated the false
positives and added 6 indeterminate results. Five of the
indeterminates were resolved positive. The OIC test
significantly improved the PPV compared with the alternate
tiebreaker algorithm alone (p < 0.001).
Compared to the serial KHB/STAT-PAK® algorithm,
the tiebreaker did significantly worse (p = 0.004). Looking
at the alternate algorithm, the difference between the
serial KHB/Unigold™ and the corresponding tiebreaker,
was not significant (p = 0.16).
Details are in Table 4.
Weak positives
51 RDT results were recorded as weak positive on
whole blood in the laboratory: 22 (N = 411) KHB, 8
STAT-PAK® (N = 411), and 21Unigold™ (N = 91). On
a total of 428 plasma samples, there were 64 weak
reactions: 21 KHB, 7 STAT-PAK®, and 36 Unigold™. The
proportion of weak positives amongst the total posi-
tive reactions in whole blood versus plasma was not
found to be significantly different with p values of 0.745,
0.79 and 0.82 for KHB, STAT-PAK®, and Unigold™
respectively.
The kappa statistic for inter-reader agreement between
the CT and the laboratory in Humera for weak versus
strong positives on whole blood was 0.85 (p < 0.001) for
KHB and 0.32 (p < 0.001) for STAT-PAK®. The kappa
statistic for inter-reader agreement between the CT and the
laboratory in Abdurafi for weak versus strong positives on
plasma was 0.79 (p < 0.001) for KHB and 0.49 (p < 0.001)
for STAT-PAK®.
The KHB/STAT-PAK® serial algorithm had 6 weak posi-
tives, 1 (17.7%) was false positive. The KHB/STAT-PAK®/
Unigold™ tiebreaker algorithm had 21 weak positive re-
sults, 16 (76.2%) were false positives. Both the serial
Table 2 Sensitivity, specificity and predictive values of individual RDTs and the OIC confirmation test (N = 2620)
RDT Results (95% Confidence interval)
Sensitivity Specificity PPV NPV
KHB 100% (98.2-100) 99.1% (98.6-99.4) 89.8% (85.1-93.4) 100% (99.8-100)
Unigold 99.0% (96.5-99.9) 99.0% (98.5-99.4) 89.3% (84.5-93.0) 99.9% (99.7-100)
STAT-PAK 100% (98.2-100) 99.9% (99.7-100) 98.5% (95.8-99.7) 99.8% (99.9-100)
Confirmation Test
OIC* 100% (98.2-100) 99.1% (96.8-99.9) 99.0% (96.5-99.9) 100% (98.4-100)
*OIC indeterminate results were classified as positive for the purpose of the analysis, however in practice, OIC indeterminate results require further testing and
cannot be used to diagnose HIV.
Table 1 Demographics of study participants
Humera
site
Abdurafi
site
Total
N (%) N (%) N (%)
Number 230 198 428
Age Mean [range] in
years
31.3 [10–65] 28.0 [10–67] 29.7 [10–67]
Sex Male 140 (61.1) 119 (60.1) 259(61.0)
Residential
status
Resident 122 (53.3) 101 (51.0) 223 (52.3)
Migrant 47 (20.5) 68 (34.3) 115 (26.9)
Settler 11 (4.8) 19 (9.6) 30 (7.0)
Other 49 (21.4) 10 (5.1) 59 (13.8)
Reason for
testing
Diagnostic testing 65 (28.4) 56 (28.3) 121 (28.3)
Symptomatic 80 (35.0) 16 (8.1) 96 (22.5)
Curious about
status
8 (3.5) 63 (31.8) 71 (16.6)
Pre-marriage 15 (6.6) 22 (11.1) 37 (8.7)
Other 61 (26.6) 41 (20.7) 102 (23.9)
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KHB/Unigold™ and the tiebreaker KHB/Unigold™/
STAT-PAK® algorithms had 35 weak positives. 16 (45.7%)
were false positive. All false positives results, regardless
of algorithm, had at least one RDT result classified as
weak positive.
Removing the weak positives from the algorithms,
significantly improved the performance of the tiebreaker
algorithm (p < 0.001) but not the serial algorithm (p = 0.30)
respectively (Table 5).
The PPV of a single weak positive RDT result versus
that of a strong positive is found in Table 6.
Description of false positives
A total of 16 individuals were identified on the tie-
breaker algorithm as false positives (FP). Table 7 contains
a breakdown of the characteristics of the false positive
samples.
The OIC results for the 16 false positives were: 13
samples: 0 reaction; 2 samples: 1 reaction; and 1 sample:
2 reactions. The cross-reacting antibodies on OIC were
p24 (3), and p31 (1). Western Blot on the same samples
had 5 negatives (zero or p17 only), and 11 indeterminate.
Individual bands detected on WB indeterminate samples
were: p24 (11), p17 (1), and p51 (1). All the OIC p24
positives were also detected on the WB.
Discussion
Our results demonstrate that the current Ethiopian
algorithm, a 3 RDT tiebreaker algorithm, has a high
proportion of false positives (7.7%) in our study popu-
lation with a HIV prevalence of 7.7%. There were 16
individuals falsely identified as HIV infected. Altering
the algorithm, such that the final tiebreaker RDT
would be STAT-PAK® rather than Unigold™ did not
improve the performance. The 3 RDTs, all exceeded
the WHO criteria for specificity (>98%) yet did not
achieve the target PPV for the algorithm of >99% [3].
This suggests that it is the choice of algorithm rather
than a poorly performing RDT that is responsible for
the high percentage of false positives.
Similar poor performances of the tiebreaker have been
reported elsewhere. A study from the Rakai cohort in
Uganda, reports a false positive proportion of 43.7%
(129/295) with a tiebreaker algorithm of Determine/
STAT-PAK®/Unigold™ at a HIV prevalence of 11.2% [4].
A separate Ugandan study in a higher prevalence
population looked at the performance of the tiebreaker
when two out of three tests were positive. 14 of 29 (48.2%)
were confirmed negative on DNA PCR [19]. In a
large study conducted in Lusaka, Zambia and Kigali,
Rwanda, samples with 2 out of 3 RDTs positive were
found to be negative for HIV infection in 17 out of
37 (46%) of cases [20].
Many authorities mistakenly assume the tiebreaker is a
WHO recommended algorithm. In fact, the WHO
recommends serial or parallel testing with 2 RDTs for high
prevalence populations (>5%), and 3 tests in series for low
Table 3 All samples recruited for the initial sample, N = 428
Algorithm N
(%)
Gold Standard result
Positive (%) Negative (%)
Serial KHB/STAT-PAK
Positive 198 198 (100%) 0
Weak positive 6 5 (83.3%) 1 (16.7%)
Negative 202 0 202 (100%)
Discordant* 22 0 22 (100%)
Serial KHB/STAT-PAK-OIC
Positive 198 198 0
Negative 203 0 203
Indeterminate 5 5 (100%) 0
Discordant* 22 0 22 (100%)
Tiebreaker: KHB/STAT-PAK/Unigold
Positive 198 198 0
Weak positive 21 5 (23.8%) 16 (76.2%)
Negative 209 0 209
Tiebreaker KHB/STAT-PAK/Unigold-OIC
Positive 198 198 (100%) 0
Indeterminate 6 5 (83.3%) 1 (16.7%)
Negative 224 0 224 (100%)
Serial KHB-Unigold
Positive 182 182 0
Weak positive 35 19 (54.3%) 16 (45.7%)
Negative 202 0 202
Discordant* 9 2 (22.2%) 7 (77.8%)
Serial KHB-Unigold-OIC
Positive 196 196 (100%) 0
Negative 217 0 217 (100%)
Indeterminate 6 5 (83.3%) 1 (16.7%)
Discordant* 9 2 (22.2%) 7 (77.8%)
Tiebreaker: KHB-Unigold-Statpak
Positive 184 184 (100%) 0
Weak positive 35 19 (54.3%) 16 (45.7%)
Negative 209 0 209 (100%)
Tiebreaker KHB-Unigold-Statpak-OIC
Positive 198 198 (100%) 0
Negative 224 0 224 (100%)
Indeterminate 6 5 (83.3%) 1 (16.7%)
TOTAL 428 203 (47.4%) 225 (52.6%)
*Discordant RDT results are reported separately because in the confirmatory
algorithms (eg KHB-Unigold-OIC), a serological confirmation test is only indicated if
both test 1 and test 2 are positive. In practice, discordant RDT results are repeated
after several weeks to rule out seroconversion.
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prevalence populations (<5%). Positive results should only
be given if all 3 tests are positive. Those with 2 out 3 tests
positive are advised they need further testing [3]. The
discordant result between two RDTs that triggers the use
of the third RDT is an indicator that cross reactivity is
occurring. In our sample, 100% of discordant results on
the serial KHB/STAT-PAK® algorithm were resolved as
negative as were 77.8% of the discordants on the alternate
KHB/Unigold™ algorithm. In the setting of discordant
results between 2 RDTs, a confirmatory test is needed
because a third RDT will be vulnerable to similar
cross-reactivity.
The KHB/STAT-PAK® serial algorithm yielded a single
false positive result. When the serial algorithm was
changed to KHB/Unigold™, the results were markedly
worse and similar to the tiebreaker regimen due to the
poor performance of Unigold™. The addition of the OIC
confirmation test to either the serial or the tiebreaker
algorithm eliminated all the false positive results. In 3
of the 4 algorithms tested, it significantly improved the
PPV compared to no confirmation test. The exception was
the serial KHB/STAT-PAK® algorithm which performed ad-
equately without a confirmation test. However the addition
of the OIC did identify one individual who otherwise would
have been falsely labelled as HIV positive.
It is important to state that these results were obtained
with a stricter interpretation of OIC, as described in the
methodology section. The results confirmed this choice;
there were no misclassifications of positive or negative
results on OIC compared to the gold standard. A drawback
to the OIC is that similar to other serological confirmation
tests, there were indeterminate tests for which a result
could not be given on the same day. There were 6 algo-
rithm positive results that were indeterminate on OIC for
Table 4 Sensitivity, specificity and predictive values of algorithms (N = 2620)
Algorithm Results (95% Confidence interval)
Sensitivity Specificity Positive predictive value Negative predictive value
Serial KHB/STAT-PAK 100% 100% 99.5% (97.3-100) 100% (98.4-100)
(98.2-100) (99.8-100)
Serial 100% 100% 100% (98.2-100) 100% (98.4-100)
KHB/STAT-PAK-OIC (98.2-100) (98.4-100)
Tiebreaker 100% 99.3% 92.7% (88.4-95.8) 100% (98.3-100)
KHB/STAT-PAK/Unigold (98.2-100) (98.9-99.6)
Tiebreaker 100% 100% 99.5% (97.3-100) 100% (98.4-100)
KHB/STAT-PAK/Unigold-OIC (98.2-100) (99.8-100)
Serial KHB/Unigold 99.0% 99.3% 92.6% (88.3-95.7) 99.9% (99.7-100)
(96.5-99.9) (98.9-99.6)
Serial KHB/Unigold-OIC 99.0% 100% 99.5% (97.3-100) 99.9% (99.7-100)
(96.5-99.9) (99.8-100)
Tiebreaker 100% 99.3% 92.7% (88.4-95.8) 100% (98.3-100)
KHB/Unigold/STAT-PAK (98.2-100) (98.9-99.6)
Tiebreaker 99.0% 100% 99.5% (97.3-100) 99.9% (99.7-100)
KHB/Unigold/STAT-PAK-OIC (96.5-99.9) (99.8-100)
Table 5 Performance characteristics of algorithms with weak positives excluded
Algorithm (95% Confidence interval)
Sensitivity Specificity Positive predictive value Negative predictive value HIV prevalence
Serial KHB/STAT-PAK 100% 100% 100% 100% 7.59%
(98.2-100) (98.4-100) (98.2-100) (98.4-100)
Tiebreaker 100% 100% 100% 100% 7.59%
KHB/STAT-PAK/Unigold (98.2-100) (98.3-100) (98.2-100) (98.3-100)
Serial KHB/Unigold 98.9% 100% 100% 99.9% 7.06%
(96.1-99.9) (98.3-100) (98.0-100) (99.7-100)
Tiebreaker 100% 100% 100% 100% 7.06%
KHB/Unigold/STAT-PAK (98.0-100) (98.3-100) (98.0-100) (98.3-100)
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the tiebreaker versus 13 on the Western Blot alone.
Looking at the serial algorithm, there were 5 OIC indeter-
minate results versus 3 for Western Blot. In calculating the
performance of the OIC algorithms, we classified these
results as positive. If the indeterminate algorithm results
are excluded from the sample, then the sensitivity, specifi-
city and predictive values of the confirmation algorithms
are all 100%. In practice patients with indeterminate results
are told their tests are inconclusive, and asked to come
back for further testing. When the result is not clarified on
repeat testing, then often a PCR is needed, as the Western
Blot is likely to show the same indeterminate result.
Finally, the OIC is one type of confirmation test that is
suitable for use in peripheral laboratories. There is an
urgent research need to develop and evaluate other
simple confirmation tests, which are affordable, cold-chain
independent, and can be performed at peripheral level.
Description of false positives
There were 5 characteristics that were significantly asso-
ciated with false positive results on univariate analysis:
age, male sex, active VL infection, the Abdurafi study
site and the time of enrolment in the study. It was not
possible to do multivariate analysis in order to explore
these associations further due to small sample size. It is
therefore difficult to conclude on the clinical significance
of these findings.
The commonest band present on the false positives
samples was p24, as 61.1% of FPs were positive for p24
by WB and 16.7% by OIC. This suggests that much of
the cross-reactivity responsible for the falsely positive
RDTs may be due to p24 and is consistent with previous
findings from Ethiopia [21]. Antibody to p24 antigen is
one of the earliest antibodies to appear, therefore raising
the possibility that our false positives were seroconverting.
However the fact that all of these cases had negative PCR
testing indicates that this is cross-reactivity rather than
early seroconversion.
Weakly reactive test lines
All of the false positive results in this review resulted from
weak positive RDT results. Excluding weak positives from
the analysis results in a 100% PPV for all the algorithms
studied. This contrasts sharply with the PPV of the weak
positive tiebreaker algorithm currently in use in Ethiopia,
which was found to be just 23.8% (95% CI 8.2-47.2). All 3
RDTs demonstrated weak positivity, though STAT-PAK®
had fewer weak lines than Unigold™ and KHB. This is the
first report of which we are aware reporting KHB weak
positives. There is evidence of Determine, STAT-PAK®,
and Unigold™ showing this phenomenon in multiple
countries which suggests this is a class effect rather than
one specific to a particular RDT or geographic location
[4,5,8,10-13]. One report suggests that weak positive
Table 6 Positive predictive value of weak RDT result
versus strong positive on plasma
Test Weak positive (95% CI) Strong positive (95% CI)
KHB 9.5% (1.2-30.4) 98.1% (95.3-99.5)
Unigold 50.0% (32.9-67.1) 96.8% (93.2-98.8)
STAT-PAK 57.1% (18.4-90.1) 100%(98.2-100)
Table 7 Characteristics of false positives compared with true positives
Variable False positives True positives p value
N (%) N (%)
Age Average 29 years 32 years p = 0.041*
Sex Male 16 (100) 111 (54.7) p = 0.000*
Female 0 92 (45.3)
Site Humera 4 (25.0) 134 (66.0) p = 0.002*
Abdurafi 12 (75.0) 113 (34.0)
Residence status Migrant 6 (37.5) 60 (29.6) p = 0.339
Settler 0 18 (8.8)
Resident 10 (62.5) 89 (43.8)
Commercial sex worker 0 23 (11.3)
Other 0 13 (6.4)
Date of visit** Mean days 122 176 p = 0.025*
CD4 Median 491[107–992] 271 [8–1051] p = 0.010*
[range]
Visceral Leishmaniasis Positive 2 (12.5) 3 (1.5) p = 0.044*
Negative 14 (87.5) 200 (98.5)
*Significant at an alpha level of 0.05.
**Days from date of first recruitment.
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results are more frequent with plasma versus whole blood
[11]. Our results do not support this finding.
The poor specificity of weak positive test lines is
consistent with that found by other researchers and is
felt to reflect the occurrence of cross reactivity. Our
results further reinforce the recommendation of a
growing body of researchers that weak positive test lines
should be interpreted as indeterminate, and require
further testing before giving a result [4,5,8,11,12]. The
exception is in the setting of blood transfusions where
any colouration of the test line should be read as
positive. Table 8 provides a summary of the data used to
support these recommendations. Given this body of
evidence, it is now time to focus research efforts on how
to implement this change in field conditions. The test
algorithm will need adaptation to incorporate the
strength of the test line. A key feasibility issue will be
the subjective nature of interpretation of the lines. We
used a reference card with photographs and were able to
achieve good agreement as evidenced by the kappa levels
of 0.79 and 0.85 for KHB. Agreement for STAT-PAK®
was less consistent, however the number of weak
positives was small. Several authors have reported good
agreement between field staff interpretation of the test
line strength and that of the reference laboratory [4,22].
However this needs to be evaluated outside of study
conditions particularly given the different cadres of staff
involved in testing. Bench aids to guide interpretation
Table 8 Summary of reports in the literature of performance of RDTs and algorithms with weak positives included
and excluded
Paper Algorithm Weak
positives
N HIV prevalence% Sensitivity
(95% CI)
Specificity
(95% CI)
PPV
(95% CI)
NPV
(95% CI)
Gray, Uganda D-S-U Included 639 14.6 97.8 94.1 74.0 99.6
D-S-U Excluded 602 14.4 97.7 99.6 97.7 99.6
Klarkowski, DRC D-U Included 2728 7.5 100 99.0 89.5 100
(98.2-100) (98.6-99.4) (84.8-93.2) (99.9-100)
D-U Excluded 2711 7.6 100 99.7 96.7 100
(98.2-100) (99.4-99.9) (93.3-98.7) (99.9-100)
Galiwango, Uganda D-S-U* Included 2520 35.2 97.4 99.6 99.3 99.8
(96.1–98.4) (99.2–99.9)
D-S-U* Excluded 35.2 97.4 99.8 99.7 99.8
(96.1–98.4) (99.5–100)
S-D-U** Included 2520 35.2 99.7 96.9 94.6 99.8
(99.0–99.9) (96.0–97.7)
S-D-U** Excluded 35.2 99.7 99.7 99.4 99.8
(99.0–99.9) (99.3–99.9)
D-S-U** Included 2520 35.2 97.4 99.7 99.4 98.6
(96.1–98.4) (99.3–99.9)
D-S-U** Excluded 35.2 97.3 99.9 99.8 98.6
(96.0–98.3) (99.6–100)
Kagulire, Uganda D Included 150 NR NR 85.2 67.3 NR
(52.9-79.7)
D Excluded 138 NR NR 95.1 NR NR
Kroidl, Tanzania D (whole blood) Included 1696 1.5 100 96.8 32.9 100
(86.7-100) (95.9-97.6) (22.8-44.4) (99.8-100)
D (whole blood) Excluded 1646 1.5 100 NR 86.2 NR
D (plasma) Included 12916 9.2 100 97.9 82.6 100
(99.7-100) (97.6-98.1) (80.5-84.5) (99.8-100)
D(plasma) Excluded 12692 9.2 100 NR 96.4 NR
S = STAT-PAK, U = Unigold, D = Determine.
DRC = Democratic Republic of Congo.
NR = Not reported.
*Parallel tiebreaker: both Determine and STAT-PAK are done initially, with discordant results resolved by Unigold.
**Serial tiebreaker: first RDT used as a screen; if negative, no further testing. If positive, second test is employed. Discordant results resolved by Unigold.
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and a simple training package need to be developed.
Finally, to avoid losing individuals to follow up, it will
be important to have timely access to confirmation
testing as well as good counselling to explain the
need for follow up testing.
While our study did not have any false positives
without weak positives on one or more RDTs, false
positive results are documented to occur with strongly
reacting test lines [5,12]. Re-classifying weak positives as
inconclusive will not therefore eliminate the risk of false
positive reactions.
The strengths of this study are its use of a standard
WHO design for evaluation of RDTs, as well as the use
of DNA PCR to resolve indeterminate OIC and Western
Blot results. The latter avoids misclassification of
severely immunosuppressed patients or seroconvertors
as false positives. The identification of the weak positive
test lines was strengthened by the use of a photo card. A
limitation is that we were unable to confirm all of the
negative results, and instead tested a random sample of
10% of the negatives. We adjusted for this in the analysis
using statistical methods.
In total, 16 individuals were misclassified as HIV
positive using the national algorithm. The consequences of
receiving a diagnosis of HIV can be devastating to an indi-
vidual and family. Four of these individuals had CD4 counts
less than 350, and 7 had counts less than 500. This suggests
that without confirmation testing, these individuals could
have been started on ART using new guidelines for ARV
initiation. The programmatic consequences of following
these individuals in HIV clinics, along with the costs for
ancillary laboratory tests are significant [13,23].
Our study suggests that these risks and costs can be
eliminated through 3 measures. Firstly, to abandon the
tiebreaker regimen in favour of a WHO approved serial
or parallel algorithm. Secondly, to consider weak positive
results as inconclusive and resolve their status through
further testing. And thirdly and most importantly, to
introduce a confirmation test to the RDT algorithm using
a test that can be performed in peripheral laboratories.
Conclusion
The risk of false positive HIV diagnosis with the tie-
breaker algorithm is significant. False diagnosis of
HIV has major consequences for individuals and for
health systems. The OIC test improves the diagnostic
accuracy of the RDT algorithm and shows good
agreement with the gold standard. Weak positive
reactions on RDTs are associated with false positive
HIV results, and require further testing prior to giving a
HIV diagnosis. It is now time to focus research efforts on
how best to translate this knowledge into practice at the
field level ensuring feasibility in the variety of settings
where HIV testing takes place.
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